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Abstract
Purpose The objective of the present study was to com-
pare the intraoperative use of tranexamic acid (TNA) plus
intra-articular diluted-epinephrine (DEP) with preoperative
autologous blood donations and transfusions in reducing an
allogeneic blood transfusion (ABT) in primary unilateral
total knee arthroplasty (TKA).
Methods Patients (n = 133) treated with unilateral pri-
mary TKA were divided into three groups retrospectively:
patients administered autologous blood transfusions were
assigned to group A (n = 51); patients administered pre-
operative injections of TNA and postoperative intra-artic-
ular injections of DEP were assigned to group B (n = 42);
and patients treated with the drain-clamp method in addi-
tion to injections of TNA and DEP were assigned to group
C( n = 40). The rate of avoidance of ABTs, postoperative
blood loss, and complications (DVT/PE, skin problems)
were examined.
Results The differences among the three groups were not
signiﬁcantinterms ofthe proportionofpatientsrequiring no
ABTs(94%ingroupA,93%ingroupBand95%ingroupC,
n.s.). The total blood loss calculated was 1,140 ± 451 ml,
852 ± 343 ml, and 850 ± 296 ml, respectively (group
B[A, group C[A, P = 0.0009). The signiﬁcant com-
plications were not observed in three groups.
Conclusion The results of the study showed that the TNA
plus DEP combination exerted a comparable effect with
preoperative autologous blood transfusion in avoiding
ABTs in unilateral primary TKA. Considering several
problems of preoperative autologous blood donation, the
use of TNA plus DEP is recommended. In addition, it is
highly possible that allogeneic blood transfusions can be
avoided for patients with preoperative Hb values C10.5
using the method described in this study, and the need for
preoperative autologous blood donations can be decreased.
Keywords Total knee arthroplasty   Allogeneic blood
transfusion   Tranexamic acid   Epinephrine  
Autologous blood donation
Introduction
Blood loss is unavoidable after total knee arthroplasty
(TKA). In recent years, a growing number of effective
agents and new techniques for avoiding allogeneic blood
transfusions (ABT) have been reported because ABTs may
lead to serious complications [10]. However, the safest and
most efﬁcient method has not been identiﬁed.
As a measure to reduce the blood transfusions and blood
loss associated with TKA, preoperative autologous blood
donations have been used since 1990. However, the pro-
cedure is associated with the problems of troublesome
administrative tasks, high costs, contraindications in
patients with anemia, and the limited storage period. Some
studies reported that an excessive volume of blood was
stored [4, 5, 7, 9, 11, 23].
As a strategy for reducing blood loss, drain clamping
has been combined with intravenous or intra-articular
administration of tranexamic acid (TNA) and intra-articu-
lar injection of diluted-epinephrine (DEP) since approxi-
mately 1995, and the preventive effect on blood loss is well
documented [3, 8, 25].
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rate of avoidance of ABTs combined with the use of TNA
and DEP in preoperative autologous blood donations and
develop a protocol for safe ABTs in TKA by combining
TNA and DEP, based on the results of the comparison. The
proposed hypothesis was that a means of using TNA plus
DEP would increase the proportion of patients who would
not require ABTs rather than preoperative autologous
blood donations.
Materials and methods
This study was a non-randomized, retrospective study that
included 133 knees undergoing unilateral primary TKA
from 2004 through 2007. All surgeries were performed by
a single surgeon (SH). General anesthesia and continuous
femoral nerve blocks were used. The implant used in all
patients was the Scorpio NRG
 posterior-stabilized type
(Stryker Howmedica Osteonics, Allendale, NJ). In all
patients, the patella was replaced, and all components were
ﬁxed with cement. Surgery was performed under tourni-
quet control. After midline skin incision, a medial para-
patellar approach was utilized. Depending on the study
period, three measures were implemented to reduce blood
loss and blood transfusions. Exclusion criteria were known
allergies to tranexamic acid, ASA-IV physical status
or higher, severe ischemia and/or heart valve disease, his-
tory of thromboembolic episodes, known coagulopathy,
and renal dysfunction (serum creatinine concentration,
[1.5 mg/dL).
(1) The autologous blood transfusion group (group A,
n = 51)
During the early study period, autologous blood was
collected on preoperative day 4 or earlier (mean, 2.2
units). Indications for preoperative autologous blood
donations were based on the Standards for Preoperative
Autologous Blood Donations (2007) developed by the
Japanese Society of Autologous Blood Transfusions.
Patients had to have a blood hemoglobin (Hb) level of
11.0 g/dL or more or a hematocrit level of 33% or more.
No age limit was established. Oral iron preparations were
administered at a daily dose of 200 mg for 1 week before
initial blood collection. When the collection of 4 or more
units of blood took 1 week or longer, 24,000 units of
recombinant human erythropoietin (ESPO
, epoetinum
alfa, Kyowa Kirin Co. Ltd., Tokyo, Japan) was adminis-
tered subcutaneously. On postoperative day 1, all patients
received autologous blood transfusions. After surgery, a
drain was inserted, and no speciﬁc postoperative blood
loss was prevented.
(2) The intravenous TNA plus intra-articular DEP group
(group B, n = 42)
Twenty minutes before surgery, 1,000 mg of TNA
(Transamin 10%
, Daiichi-Sankyo Co. Ltd., Tokyo, Japan)
was administered intravenously. After wound closure,
50 mL of epinephrine diluted to 1:200,000 was injected
intra-articularly without drain insertion.
(3) The intravenous TNA plus intra-articular DEP plus
drain-clamping group (group C, n = 40)
As in the case of group B, TNA was administered
intravenously. When the wound was closed, however, an
intra-articular drain was inserted, and 50 mL of epineph-
rine diluted to 1:200,000 was injected intra-articularly. The
suction drain was clamped for the ﬁrst 3 h and then
unclamped in group C. The drain was removed 48 h later
in groups A and C. As part of the postoperative care for the
three groups, continuous passive movement was started on
postoperative day 3, and standing and full-weight-bearing
walking were allowed.
Bleeding-related outcome measures included changes in
Hb, drained blood loss (group A and C), total postoperative
blood loss, proportion of patients requiring no allogenic
blood transfusions, and complications related to the pre-
vention of blood loss. Hb levels were measured on the day
before surgery and postoperative days 1, 4, and 7. A for-
mula proposed by Nadler et al. [20] and Sehat et al. [24]
was used to calculate the total postoperative blood loss.
The loss of Hb was then estimated according to the fol-
lowing formula:
Bloodvolume l ðÞ¼height m ðÞ
3  0:356
þbody weight kg ðÞ   0:033
þ0:183 woman ðÞ
¼ height m ðÞ
3  0:367
+ body weight kg ðÞ
  0:032þ0:604 man ðÞ
Hbloss g ðÞ ¼ Bloodvolume   10   Hbi   Hbfin ðÞ þ Hbt
Totalbloodloss ml ðÞ ¼ Hbloss=Hbi   100
where Hbloss (g) was the amount of Hb lost, Hbi (g/dl) was
the Hb concentration before surgery, Hbﬁn (g/dl) was the
Hb concentration on postoperative day 4 or 7 (whichever
was lower), and Hbt (g) was the total amount of allogeneic
and autologous Hb transfused.
To investigate the inﬂuence on the development of
postoperative deep vein thrombosis (DVT) and pulmonary
embolisms (PE), contrast-enhanced computed tomography
(CT) was performed in patients with a D-dimer level of
20 lg/mL or more on postoperative days 1, 4, 7, and 14
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Images were read by two radiologists. Patients with a
diagnosis of DVT or PE and those with persistently ele-
vated D-dimer levels received continuous heparin infusion
and oral warfarin therapy. Oral warfarin was continued for
3 months. Oral therapy was controlled to achieve a target
INR of 2–3. On postoperative day 14, patients were also
examined for postoperative skin disorders (skin necrosis,
skin loss, and superﬁcial infections).
Statistical analysis
ANOVA and an unpaired t-test were used to analyze
parametric data, whereas a chi-square test among the three
groups was used for non-parametric data. When a signiﬁ-
cant difference was found, groups were compared using the
Bonferroni method. A P-value of 0.05 or less was con-
sidered a signiﬁcant difference.
Results
Among the three groups, there were no signiﬁcant differ-
ences in patient characteristics of gender, age, underlying
disease, body weight, and height (Table 1). At any point in
time (preoperative day and postoperative day 1, 4, or 7),
there were no signiﬁcant differences among the three
groups (Table 2, postoperative Hb). The postoperative
drained blood loss (Table 2) was 535 ± 212 mL and
328 ± 109 mL in groups A and C, respectively, indicating
a signiﬁcant reduction in group C (P = 0.00001). As
shown in Fig. 1, the total postoperative blood loss in
groups B and C was signiﬁcantly less than that in group A
(P = 0.0009). In Table 2, the proportion of patients
requiring no ABTs was 94% (48/51) in group A, 93% (39/
42) in group B, and 95% (38/40) in group C, with no
signiﬁcant differences among the three groups. Finally, in
the development of DVT and PE (Table 3), there were no
signiﬁcant differences among the three groups. All cases of
PE were asymptomatic. As for skin conditions (Table 3),
there were no signiﬁcant differences among the three
groups for complications in the wound area.
Discussion
The most important ﬁnding of the present study was that
the rate of avoidance of ABT in TNA plus the combination
of DEP was similar to that of preoperative autologous
Table 1 Patient characteristics
Group A Group B Group C P value
(n = 51) (n = 42) (n = 40)
Gender (male/female) 4/47 6/36 5/35 n.s.
Age (year) 70 ± 10 68 ± 96 5 ± 12 n.s.
Disease (RA/OA) 16/35 20/22 18/22 n.s.
Body weight (kg) 55 ± 10 55 ± 11 56 ± 9.5 n.s.
Height (cm) 149 ± 10 150 ± 8.7 151 ± 7.9 n.s.
Values are expressed as mean ± SD. There was no signiﬁcant dif-
ference in every category
RA rheumatoid arthritis, OA osteoarthritis
Table 2 Hemoglobin (Hb) level concentrations before and after
operation and drained blood loss, transfusion requirements
Group A Group B Group C P value
Preoperative Hb
(g/dl)
12.0 ± 1.0 12.2 ± 1.6 12.4 ± 1.4 n.s.
Postoperative Hb (g/dl)
Day 1 9.4 ± 1.5 10.1 ± 1.3 10.0 ± 1.2 n.s.
Day 4 9.4 ± 1.3 9.3 ± 1.2 8.9 ± 1.5 n.s.
Day 7 9.6 ± 1.4 9.5 ± 1.3 9.1 ± 1.6 n.s.
Fall in Hb (g/dl)
Preop–day 1 2.3 ± 1.4 2.4 ± 0.9
Day 1–day 4 1.0 ± 1.2 1.1 ± 1.1
Drained blood loss
(ml)
535 ± 212 328 ± 109 0.00001
Allogeneic transfusion needs
Number of patients 3 3 2 n.s.
Avoidance rate (%) 94 93 95
Values are expressed as mean ± SD
Fig. 1 Total postoperative blood loss
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123blood transfusions. Considering the several problems of
preoperative autologous blood donations [4, 5, 7, 9, 11,
23], DEP plus TNA can be a more effective method of
handling postoperative blood loss in avoiding ABT.
Since the reports by Benoni et al. [3], many groups have
reported the usefulness of TNA in TKA [1, 6, 19, 21]. Cid
et al. [8] performed a meta-analysis of the use of TNA in
reducing blood loss in TKA and reported that the use of
TNA signiﬁcantly reduced the number of patients requiring
blood transfusions and the volume of each blood transfu-
sion. Although complications due to thrombosis caused by
ﬁbrinolytic inhibition have been a concern, there have been
no reports of such complications [25]. Similarly, there were
no signiﬁcant differences in the incidence of DVT or PE
among the three groups.
The effect of drain clamping plus DEP after TKA has
been controversial. Anderson et al. [2] and Gasparini et al.
[12] reported that intra-articular injections of DEP
decreased blood loss after TKA. On the other hand, Malone
et al. [16] reported that intra-articular injections of DEP
were not effective. Some reports suggest that long periods
of DEP plus drain clamping increased the development of
skin lesions [12, 16]. In the current study, the hemostatic
effect of intra-articular injection of DEP alone and the
incidence of complications were not compared. However,
skin disorders did not occur more frequently in group B in
which no drain was inserted. Actually, swelling of the thigh
and lower leg during the ﬁrst two weeks after surgery was
more severe in group B (no drain inserted) than in group C.
Thus, measures to reduce blood are now implemented as in
group C.
Some studies have recently stressed the importance of
establishing an ABT protocol as a way to reduce post-
operative blood loss and blood transfusions [14, 15, 17].
In other studies, it has been reported that the preoperative
Hb level is a risk factor for postoperative blood trans-
fusions [13, 14, 18, 22]. Predicting the lowest postoper-
ative Hb level from the preoperative Hb level, Jeffery
et al. [15] developed and implemented an algorithm for
ABTs. The authors reported a 14% reduction in the rate
of blood transfusions. Analysis of the change in Hb from
baseline in patients showed that the Hb levels in groups
B and C decreased by 2.3 and 2.4 g/dL, respectively, on
postoperative day 1 and further decreased by 1.0 and
1.1 g/dL, respectively, on postoperative day 4. Thus,
there were overall decreases of 3.3 and 3.5 g/dL in
groups B and C, respectively (Table 2). The guidelines
from the blood transfusion committee in the hospital
indicate that the Hb level at which ABTs are indicated is
7–8 g/dL in patients without cardiovascular and other
systemic symptoms who undergo elective orthopedic
surgery. Given that an Hb level of 7 g/dL or less is
an indication of ABTs, concomitant use of intravenous
TNA and postoperative intra-articular injections of DEP
potentially eliminates the need for blood transfusions in
patients with a preoperative Hb level of 10.5 g/dL or
more. An algorithm was developed: when the Hb level on
postoperative day 1 decreases to 7–8 g/dL, ABTs may be
necessary depending on the patient’s condition. When the
Hb level on postoperative day 1 ranges from 8 to 9 g/dL,
decisions are made on the basis of hematologic test
results on postoperative day 4 (Fig. 2). Treatment is now
provided according to this algorithm without preoperative
autologous blood donations.
The present study had several limitations. This was a
retrospective study. Although there were no differences in
patient characteristics among the three groups, selection
bias was not completely excluded in this study. The syn-
ergistic effect of administration of TNA or intra-articular
DEP was not investigated. Both the administration of TNA
and intra-articular DEP reduced postoperative blood loss
after tourniquet release, and further studies (RCTs) are
needed to determine dosage and administration. The clin-
ical relevance of this study was that the combination of
TNA and DEP might supplant autologous blood transfu-
sions in order to reduce ABTs in unilateral primary TKA.
Table 3 Postoperative complications
Group A Group B Group C P value
Number of DVT 10 7 9 n.s.
Number of PE 1 1 2 n.s.
Number of skin trouble
(necrosis, loss, infection)
2 1 1 n.s.
Values are expressed as mean ± SD or number
DVT deep venous thrombosis, PE pulmonary embolism
Fig. 2 Our recommended allogeneic blood transfusion protocol in
primary TKAs
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123Conclusion
The results of the current study demonstrated that the TNA
plus DEP combination exerted a comparable effect with
preoperative autologous blood transfusions in avoiding
ABTs in unilateral primary TKA. Considering the several
problems of preoperative autologous blood donation, the
use of TNA and DEP is recommended to prevent blood
loss. In addition, allogeneic blood transfusions may be
avoided for patients with Hb values C10.5 by using this
method, and the need for preoperative autologous blood
donations can be decreased.
Acknowledgments The authors would like to express their grati-
tude to Eiryo Kawakami, MD, and Daisuke Tamura, MD, for editing
the manuscript and for editorial assistance.
Open Access This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which per-
mits any noncommercial use, distribution, and reproduction in any
medium, provided the original author(s) and source are credited.
References
1. Alvarez JC, Santiveri FX, Ramos I, Vela E (2008) Tranexamic
acid reduces blood transfusion in total knee arthroplasty even
when a blood conservation program is applied. Transfusion
48:519–525
2. Anderson LA, Engel GM, Bruckner JD, Stoddard GJ (2009)
Reduced blood loss after total knee arthroplasty with local
injection of bupivacaine and epinephrine. J Knee Surg 22:
130–136
3. Benoni G, Fredin H (1996) Fibrinolytic inhibition with tranex-
amic acid reduces blood loss and blood transfusion after knee
arthroplasty: a prospective, randomised, double-blind study of 86
patients. J Bone Joint Surg Br 78:434–440
4. Bierbaum BE, Callaghan JJ, Galante JO, Rubash HE, Tooms RE,
Welch RB (1999) An analysis of blood management in patients
having a total hip or knee arthroplasty. J Bone Joint Surg Am
81:2–10
5. Billote DB, Glisson SN, Green D, Wixson RL (2002) A pro-
spective, randomized study of preoperative autologous donation
for hip replacement surgery. J Bone Joint Surg Am 84:1299–1304
6. Camarasa MA, Olle G, Serra-Prat M, Martin A (2006) Efﬁcacy of
aminocaproic, tranexamic acids in the control of bleeding during
total knee replacement: a randomized trial. Br J Anaesth
96:576–582
7. Chun TY, Martin S, Leptor H (1997) Preoperative recombinant
human erythropoietin injection versus preoperative autologous
blood donation in patients undergoing radical retropubic prosta-
tectomy. Urology 50:727–732
8. Cid J, Lozano M (2005) Tranexamic acid reduces allogeneic red
cell transfusions in patients undergoing total knee arthroplasty:
results of a meta-analysis of randomized controlled trials.
Transfusion 45:1302–1307
9. Cohen JA, Brecher ME (1995) Preoperative autologous blood
donation: beneﬁt or detriment? A mathematical analysis. Trans-
fusion 35:640–644
10. Earnshaw P (2001) Blood conversation in orthopaedic surgery:
the role of epoetin. Int Orthop 25:273–278
11. Ecthason J, Petz L, Keeler E, Calhoun L, Kleinman S, Snider C,
Fink A, Brook R (1995) The cost effectiveness of preoperative
autologous donations. N Engl J Med 332:719–724
12. Gasparini P, Papaleo P, Pola S, Cerciello E, Pola C (2006) Local
infusion of norepinephrine reduces blood losses and need of
transfusion in total knee arthroplasty international orthopaedics.
SICOT 30:253–256
13. Hatzidakis AM, Mendlick RM, McKillip T, Reddy RL (2000)
Preoperative autologous donation for total joint arthroplasty. An
analysis of risk factors for allogenic transfusion. J Bone Joint
Surg 82:89–100
14. Helm AT, Karski MT, Parsons SJ, Sampath JS (2003) A strategy
for reducing blood-transfusion requirements in elective ortho-
paedic surgery. Audit of an algorithm for arthroplasty of the
lower limb. J Bone Joint Surg Br 85:484–489
15. Jeffery LP, Timothy JH, Donald RE (2004) A blood-conservation
algorithm to reduce blood transfusions after total hip and knee
arthroplasty. J Bone Joint Surg Am 86:1512–1518
16. Malone KJ, Matuszak S, Mayo D, Greene P (2009) The effect of
intra-articular epinephrine lavage on blood loss following total
knee arthroplasty. Orthopedics 32:100–103
17. Martinez V, Monsaingeon-Lion A, Cherif K, Judet T (2007)
Transfusion strategy for primary knee and hip arthroplasty:
impact of an algorithm to lower transfusion rates and hospital
costs. Br J Anaesth 99:794–800
18. Mesa-Romas F, Mesa-Romas M, Maquieira-Canosa C (2008)
Predictors for blood transfusion following total knee Arthro-
plasty: a prospective randomized study. Acta Orthop Belg
74:83–89
19. Molloy DO, Archbold HA, Ogonda L, McConway J (2007)
Comparison of topical ﬁbrin spray and tranexamic acid on blood
loss after total knee replacement: a prospective, randomized
controlled trial. J Bone Joint Surg Br 89:306–309
20. Nadler SB, Hidalgo JU, Blouch T (1962) Prediction of blood
volume in normal human adults. Surgery 51:224–232
21. Ralley FE, Berta D, Binns V, Howard J (2010) One intraoperative
dose of tranexamic acid for patients having primary hip or knee
arthroplasty. Clin Orthop Relat Res 468:1905–1911
22. Salido JA, Marı ´n LA, Go ´mez LA, Zorrilla P, Martı ´nez C (2002)
Preoperative hemoglobin levels and the need for transfusion after
prosthetic hip and knee surgery: analysis of predictive factors.
J Bone Joint Surg Am 84:216–220
23. Spahn DR, Casutt M (2000) Eliminating blood transfusion: new
aspects and perspectives. Anesthesiology 93:242–255
24. Sehat KR, Evans RL, Newman JH (2004) Hidden blood loss
following hip and knee arthroplasty. Correct management of
blood loss should take hidden loss into account. J Bone Joint Surg
Br 86:561–565
25. Tanaka N, Sakahashi H, Sato E, Hirose K, Ishima T, Ishii S
(2001) Timing of the administration of tranexamic acid for
maximum reduction in blood loss in arthroplasty of the knee.
J Bone Joint Surg Br 83:702–705
Knee Surg Sports Traumatol Arthrosc (2011) 19:921–925 925
123